Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin R Pritchard

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Iscience|November 26, 2021
Genomic and experimental evidence that ALK<sup>ATI</sup> does not predict single agent sensitivity to ALK inhibitorsHaider Inam, Ivan Sokirniy, Yiyun Rao, et al.
Cell|March 1, 2016
Exploiting Temporal Collateral Sensitivity in Tumor Clonal EvolutionBoyang Zhao, Joseph C Sedlak, Raja Srinivas, et al.
Cancer Research|July 26, 2011
Bcl-2 family genetic profiling reveals microenvironment-specific determinants of chemotherapeutic responseJustin R Pritchard, Luke A Gilbert, Corbin E Meacham, et al.
Nucleic Acids Research|August 1, 2013
High-resolution definition of the Vibrio cholerae essential gene set with hidden Markov model-based analyses of transposon-insertion sequencing dataMichael C Chao, Justin R Pritchard, Yanjia J Zhang, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|June 26, 2021
Synthesis, structure and anticancer properties of new biotin- and morpholine-functionalized ruthenium and osmium half-sandwich complexesMickaël Marloye, Haider Inam, Connor J Moore, et al.
Nature Biotechnology|July 4, 2024
Programming tumor evolution with selection gene drives to proactively combat drug resistanceScott M Leighow, Joshua A Reynolds, Ivan Sokirniy, et al.
Plos Genetics|November 7, 2014
ARTIST: high-resolution genome-wide assessment of fitness using transposon-insertion sequencingJustin R Pritchard, Michael C Chao, Sören Abel, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2020
The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoningPeter M Bruno, Mengrou Lu, Kady A Dennis, et al.
Nature Medicine|March 7, 2017
A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stressPeter M Bruno, Yunpeng Liu, Ga Young Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2018
Single-Molecule Sequencing Reveals Patterns of Preexisting Drug Resistance That Suggest Treatment Strategies in Philadelphia-Positive LeukemiasMichael W Schmitt, Justin R Pritchard, Scott M Leighow, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Iscience|November 26, 2021
Genomic and experimental evidence that ALK<sup>ATI</sup> does not predict single agent sensitivity to ALK inhibitorsHaider Inam, Ivan Sokirniy, Yiyun Rao, et al.
Cell|March 1, 2016
Exploiting Temporal Collateral Sensitivity in Tumor Clonal EvolutionBoyang Zhao, Joseph C Sedlak, Raja Srinivas, et al.
Cancer Research|July 26, 2011
Bcl-2 family genetic profiling reveals microenvironment-specific determinants of chemotherapeutic responseJustin R Pritchard, Luke A Gilbert, Corbin E Meacham, et al.
Nucleic Acids Research|August 1, 2013
High-resolution definition of the Vibrio cholerae essential gene set with hidden Markov model-based analyses of transposon-insertion sequencing dataMichael C Chao, Justin R Pritchard, Yanjia J Zhang, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|June 26, 2021
Synthesis, structure and anticancer properties of new biotin- and morpholine-functionalized ruthenium and osmium half-sandwich complexesMickaël Marloye, Haider Inam, Connor J Moore, et al.
Nature Biotechnology|July 4, 2024
Programming tumor evolution with selection gene drives to proactively combat drug resistanceScott M Leighow, Joshua A Reynolds, Ivan Sokirniy, et al.
Plos Genetics|November 7, 2014
ARTIST: high-resolution genome-wide assessment of fitness using transposon-insertion sequencingJustin R Pritchard, Michael C Chao, Sören Abel, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2020
The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoningPeter M Bruno, Mengrou Lu, Kady A Dennis, et al.
Nature Medicine|March 7, 2017
A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stressPeter M Bruno, Yunpeng Liu, Ga Young Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2018
Single-Molecule Sequencing Reveals Patterns of Preexisting Drug Resistance That Suggest Treatment Strategies in Philadelphia-Positive LeukemiasMichael W Schmitt, Justin R Pritchard, Scott M Leighow, et al.
Pageof 5